A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 11, 2007, Pages 2304-2313

  Hogervorst, Janneke G ^a   Schouten, Leo J ^a   Konings, Erik J ^b   Goldbohm, R Alexandra ^c   Van Den Brandt, Piet A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Voedsel en Waren Autoriteit Netherlands   (Netherlands)

^c TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CASE STUDY; CHEMICAL ANALYSIS; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIETARY INTAKE; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; FOOD INTAKE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; OVARY CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SMOKING;

ACRYLAMIDE; AGED; BREAST NEOPLASMS; COHORT STUDIES; DIET; DIET SURVEYS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NETHERLANDS; OVARIAN NEOPLASMS; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 38849162044     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0581     Document Type: Article

References (53)

1. Tareke E, Rydberg P, Karlsson P, Eriksson S, Tornqvist M. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem 2002;50:4998-5006.
2. Summary and conclusions of the sixty-fourth meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA): JECFA, 2005.
3. IARC. Monographs on the evaluation of carcinogen risk to humans: some industrial chemicals. Lyon: IARC; 1994.
4. Dybing E, Farmer PB, Andersen M, et al. Human exposure and internal dose assessments of acrylamide in food. Food Chem Toxicol 2005;43:365-410.
5. Konings EJ, Baars AJ, van Klaveren JD, et al. Acrylamide exposure from foods of the Dutch population and an assessment of the consequent risks. Food Chem Toxicol 2003;41:1569-79.
6. Mottram DS, Wedzicha BL, Dodson AT. Acrylamide is formed in the Maillard reaction. Nature 2002;419:448-9.
7. Stadler RH, Blank I, Varga N, et al. Acrylamide from Maillard reaction products. Nature 2002;419:449-50.
8. Taeymans D, Wood J, Ashby P, et al. A review of acrylamide: an industry perspective on research, analysis, formation, and control. Crit Rev Food Sci Nutr 2004;44:323-47.
9. Johnson KA, Gorzinski SJ, Bodner KM, et al. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 1986;85:154-68.
10. Bull RJ, Robinson M, Laurie RD, et al. Carcinogenic effects of acrylamide in Sencar and A/J mice. Cancer Res 1984;44:107-11.
11. Bull RJ, Robinson M, Stober JA. Carcinogenic activity of acrylamide in the skin and lung of Swiss-ICR mice. Cancer Lett 1984;24:209-12.
12. Friedman MA, Dulak LH, Stedham MA. A lifetime oncogenicity study in rats with acrylamide. Fundam Appl Toxicol 1995;27:95-105.
13. Marsh GM, Lucas LJ, Youk AO, Schall LC. Mortality patterns among workers exposed to acrylamide: 1994 follow up. Occup Environ Med 1999;56:181-90.
14. Schulz MR, Hertz-Picciotto I, van Wijngaarden E, Hernandez JC, Ball LM. Dose-response relation between acrylamide and pancreatic cancer. Occup Environ Med 2001;58:609.
15. Sobel W, Bond GG, Parsons TW, Brenner FE. Acrylamide cohort mortality study. Br J Ind Med 1986;43:785-8.
16. Collins JJ, Swaen GM, Marsh GM, Utidjian HM, Caporossi JC, Lucas LJ. Mortality patterns among workers exposed to acrylamide. J Occup Med 1989;31:614-7.
17. Swaen GM, Haidar S, Burns CJ, et al. Mortality study update of acrylamide workers. Occup Environ Med 2007;64:396-401.
18. Marsh GM, Youk AO, Buchanich JM, Kant IJ, Swaen G. Mortality patterns among workers exposed to acrylamide: updated follow up. J Occup Environ Med 2007;49:82-95.
19. Pelucchi C, Galeone C, Levi F, et al. Dietary acrylamide and human cancer. Int J Cancer 2006;118:467-71.
20. Mucci LA, Dickman PW, Steineck G, Adami HO, Augustsson K. Dietary acrylamide and cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden. Br J Cancer 2003;88:84-9.
21. Mucci LA, Lindblad P, Steineck G, Adami HO. Dietary acrylamide and risk of renal cell cancer. Int J Cancer 2004;109:774-6.
22. Mucci LA, Adami HO, Wolk A. Prospective study of dietary acrylamide and risk of colorectal cancer among women. Int J Cancer 2006;118:169-73.
23. Mucci LA, Sandin S, Balter K, Adami HO, Magnusson C, Weiderpass E. Acrylamide intake and breast cancer risk in Swedish women. Jama 2005;293:1326-7.
24. Zhang M, Yang ZY, Binns CW, Lee AH. Diet and ovarian cancer risk: a case-control study in China. Br J Cancer 2002;86:712-7.
25. Michels KB, Rosner BA, Chumlea WC, Colditz GA, Willett WC. Preschool diet and adult risk of breast cancer. Int J Cancer 2006;118:749-54.
26. van den Brandt PA, Goldbohm RA, van 't Veer P, Volovics A, Hermus RJ, Sturmans F. A large-scale prospective cohort study on diet and cancer in the Netherlands. J Clin Epidemiol 1990;43:285-95.
27. Goldbohm RA, van den Brandt PA, Dorant E. Estimation of the coverage of Dutch municipalities by cancer registries and PALGA based on hospital discharge data. Tijdschr Soc Gezondheidsz 1994;72:80-84.
28. van den Brandt PA, Schouten LJ, Goldbohm RA, Dorant E, Hunen PM. Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research. Int J Epidemiol 1990;19:553-8.
29. Goldbohm RA, van den Brandt PA, Brants HA, et al. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur J Clin Nutr 1994;48:253-65.
30. Goldbohm RA, van 't Veer P, van den Brandt PA, et al. Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five annually repeated measurements. Eur J Clin Nutr 1995;49:420-9.
31. Database of the European Commission Institute for Reference Materials and Measurements (IRMM; accessed August 3, 2006, at http://www.irmm.jrc.be/html/ activities/acrylamide/database.htm).
32. Schottenfeld D, Fraumeni JF, Jr. Cancer epidemiology and prevention. New York City: Oxford University Press; 2006.
33. Schettgen T, Rossbach B, Kutting B, Letzel S, Drexler H, Angerer J. Determination of haemoglobin adducts of acrylamide and glycidamide in smoking and non-smoking persons of the general population. Int J Hyg Environ Health 2004;207:531-9.
34. Bergmark E. Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers. Chem Res Toxicol 1997;10:78-84.
35. Ardies CM, Smith TJ, Kim S, Yang CS. Induction of 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK) activation in rat lung microsomes by chronic ethanol consumption and repeated running exercise. Cancer Lett 1996;103:209-18.
36. Ghanayem BI, Witt KL, Kissling GE, Tice RR, Recio L. Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: evidence consistent with a glycidamide-mediated effect. Mutat Res 2005;578:284-97.
37. Howard LA, Micu AL, Sellers EM, Tyndale RF. Low doses of nicotine and ethanol induce CYP2E1 and chlorzoxazone metabolism in rat liver. J Pharmacol Exp Ther 2001;299:542-50.
38. Wang Z, Hall SD, Maya JF, Li L, Asghar A, Gorski JC. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. Br J Clin Pharmacol 2003;55:77-85.
39. Cai J, Zeng D. Sample size/power calculation for case-cohort studies. Biometrics 2004;60:1015-24.
40. Wenzl T, Karasek L, Rosen J, et al. Collaborative trial validation study of two methods, one based on high performance liquid chromatography-tandem mass spectrometry and on gas chromatography-mass spectrometry for the determination of acrylamide in bakery and potato products. J Chromatogr A 2006;1132:211-8.
41. Stadler RH. Acrylamide formation in different foods and potential strategies for reduction. Adv Exp Med Biol 2005;561:157-69.
42. Amrein TM, Andres L, Manzardo GG, Amado R. Investigations on the promoting effect of ammonium hydrogen carbonate on the formation of acrylamide in model systems. J Agric Food Chem 2006;54:10253-61.
43. Dybing E, Sanner T. Risk assessment of acrylamide in foods. Toxicol Sci 2003;75:7-15.
44. Gamboa da Costa G, Churchwell MI, Hamilton LP, et al. DNA adduct formation from acrylamide via conversion to glycidamide in adult and neonatal mice. Chem Res Toxicol 2003;16:1328-37.
45. Doerge DR, da Costa GG, McDaniel LP, Churchwell MI, Twaddle NC, Beland FA. DNA adducts derived from administration of acrylamide and glycidamide to mice and rats. Mutat Res 2005;580:131-41.
46. Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P. Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann N Y Acad Sci 2001;943:296-315.
47. Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 1983;71:717-21.
48. Exon JH. A review of the toxicology of acrylamide. J Toxicol Environ Health B Crit Rev 2006;9:397-412.
49. Park J, Kamendulis LM, Friedman MA, Klaunig JE. Acrylamide-induced cellular transformation. Toxicol Sci 2002;65:177-83.
50. Health implications of acrylamide in food. Report of a Joint FAO/WHO Consultation.: FAO/WHO; 2002.
51. Swiss Federal Office of Public Health. Assessment of acrylamide intake by duplicate diet study. 2002. (accessed August 3, 2006, at http://www.bag.admin. ch).
52. Matthys C, Bilau M, Govaert Y, Moons E, De Henauw S, Willems JL. Risk assessment of dietary acrylamide intake in Flemish adolescents. Food Chem Toxicol 2005;43:271-8.
53. Acrylamide Status Report December 2004: a summary of the efforts and progress achieved to date by the European food and drink industry (CIAA) in lowering levels of acrylamide in food. Bruxelles: CIAA; 2004.